Jie H Chen

Address:

4065 S Braeswood Blvd, Houston, TX 77025

VIN:

1HGFA16517L062646

Make:

HONDA

Model:

CIVIC

Year:

2007

US Patent:

7062574, Jun 13, 2006

Filed:

May 11, 2000

Appl. No.:

09/568687

Inventors:

Jie Chen - Bridgewater NJ, US
Jit Kumar - Basking Ridge NJ, US

Assignee:

Agere Systems Inc. - Allentown PA

International Classification:

G06F 15/16

US Classification:

709250, 709230, 709236, 709245

Abstract:

A system for, and method of, selectively detaching point-to-point protocol header information from a packet received from a network and a network adapter incorporating the system or the method. In one embodiment, the system includes: (1) a sub-protocol detector that receives the packet and identifies therefrom a sub-protocol employed with respect to the packet and (2) a header detacher, coupled to the sub-protocol detector, that detaches at least some of the point-to-point protocol header information from the packet based on an identity of the sub-protocol thereby to reduce an overall size of the packet.

US Patent:

7288538, Oct 30, 2007

Filed:

Aug 23, 2004

Appl. No.:

10/924180

Inventors:

Chengde Wu - Pearland TX, US
Daxin Gao - Houston TX, US
Ronald Biediger - Houston TX, US
Jie Chen - Houston TX, US
Robert V. Market - Pearland TX, US

Assignee:

Encysive Pharmaceuticals, Inc. - Houston TX

International Classification:

A61K 31/5375
A61K 31/4523
A61K 31/4025
A61K 31/381
C07D 413/10
C07D 409/10

US Classification:

51421019, 5142315, 514326, 514422, 514444, 544146, 546213, 548527, 548950, 549 59, 549 60

Abstract:

The present invention relates to urotensin II receptor antagonists, CCR-9 antagonists, pharmaceutical compositions containing them and their use.

US Patent:

7579340, Aug 25, 2009

Filed:

Aug 22, 2007

Appl. No.:

11/895069

Inventors:

Ronald Biediger - Houston TX, US
Jie Chen - Houston TX, US
Daxin Gao - Houston TX, US
Robert Market - Pearlman TX, US
Chengde Wu - Pearland TX, US

Assignee:

Pfizer Inc - New York NY

International Classification:

A61K 31/5375
A61K 31/4523
A61K 31/4025
A61K 31/381
C07D 413/10
C07D 409/10

US Classification:

51421019, 5142315, 514326, 514422, 514444, 544146, 546213, 548527, 548950, 549 59, 549 60

Abstract:

The present invention relates to urotensin II receptor antagonists, CCR-9 antagonists, pharmaceutical compositions containing them and their use.

US Patent:

8178699, May 15, 2012

Filed:

Jul 30, 2008

Appl. No.:

12/183032

Inventors:

Eric C Anderson - Irving TX, US
Ronald J Biediger - Houston TX, US
Jie Chen - Houston TX, US
Brian Dupre - Houston TX, US
Pedro Lory - Antwerp, BE
Robert V. Market - Pearland TX, US
Keith A. Monk - League City TX, US
Michael M. Savage - Pearland TX, US
Reginald Tennyson - Missouri City TX, US
Brandon M. Young - Germantown TN, US

Assignee:

Pfizer Inc. - New York NY

International Classification:

C07D 333/56

US Classification:

549 57

Abstract:

Provided are compounds that are modulators of CCR9 receptor activity, compositions containing the compounds and methods of use of the compounds and compositions. In certain embodiments, provided are methods for treating or ameliorating diseases associated with modulation of CCR9 receptor activity.

US Patent:

20080188528, Aug 7, 2008

Filed:

Dec 21, 2007

Appl. No.:

12/004956

Inventors:

Ronald J. Biediger - Houston TX, US
Huong M. Bui - Pearland TX, US
Jie Chen - Houston TX, US
Kevin M. Henry - Pearland TX, US
Thomas Thrash - Houston TX, US

International Classification:

A61K 31/4439
C07D 213/02
A61K 31/44
A61K 31/381
A61K 31/34
A61P 25/00
A61P 31/00
A61P 15/08
A61P 9/00
C07D 307/34
C07D 333/02
A61K 31/19

US Classification:

514341, 546298, 514350, 514557, 562400, 5462747, 549 29, 514438, 549487, 514461

Abstract:

Provided are compounds that are modulators of C3a receptor activity, compositions containing the compounds and methods of use of the compounds and compositions. In certain embodiments, the compounds are pyridones. In certain embodiments, provided are methods for treatment or amelioration of diseases associated with modulation of C3a receptor activity.

US Patent:

20080271603, Nov 6, 2008

Filed:

May 4, 2007

Appl. No.:

11/800311

Inventors:

Carl Triplett - Scottsdale AZ, US
Michael Mathiesen - Scottsdale AZ, US
Jie Chen - Scottsdale AZ, US
Geoffrey Faires - Cave Creek AZ, US

International Classification:

B01D 47/02
B01D 47/04
B01D 53/14
F28B 9/00

US Classification:

95150, 62172, 95226, 96290, 96329

Abstract:

An air purification system and method of purifying air according to various embodiments of the invention includes an ambient air inlet and a purified air outlet for the passage there through of air via a transport line. At least one cleaning chamber configured to contain therein an aqueous solution containing a reactant medium is in fluidic communication with the transport line. The ambient air passes through the at least one cleaning chamber and bubbles through the aqueous solution reacting with the reactant medium contained therein to remove gaseous pollutants and/or particulates. To recharge the system, a user simply changes out the cleaning chamber when the reactant medium is no longer capable of reacting to remove the gaseous pollutants and/or particulates from air passing there through.

US Patent:

20220315580, Oct 6, 2022

Filed:

Dec 9, 2020

Appl. No.:

17/116016

Inventors:

- Princeton NJ, US
Amy C. Hart - Ewing NJ, US
John E. Macor - Washington Crossing PA, US
Michael E. Mertzman - New Hope PA, US
William J. Pitts - Newtown PA, US
Steven H. Spergel - Warrington PA, US
Scott Hunter Watterson - Pennington NJ, US
Murugaiah Andappan Murugaiah Subbaiah - Tamil Radu, IN
Jie Chen - Cambridge MA, US
Carolyn Diane Dzierba - Middletown CT, US
Guanglin Luo - Newtown PA, US
Jianliang Shi - Furlong PA, US

International Classification:

C07D 471/04

Abstract:

Compounds having formula (I)-(IX), and enantiomers, and diastereomers, stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, are useful as kinase modulators, including RIPK1 modulation. All the variables are as defined herein.

US Patent:

20230060623, Mar 2, 2023

Filed:

Aug 24, 2021

Appl. No.:

17/410617

Inventors:

- Atlanta GA, US
Wenjie Zhao - Princeton NJ, US
Jie Chen - Watchung NJ, US

International Classification:

H04L 12/851
H04L 12/803
H04L 12/26

Abstract:

Intelligent, adaptive scheduling weight adjustment is enabled, e.g., to improve network performance. For instance, A non-transitory machine-readable medium can comprise executable instructions that, when executed by a processor, facilitate performance of operations, comprising based on key performance indicators corresponding to data traffic flows via a network, determining quality of service data representative of respective qualities of service for the data traffic flows, using a scheduling weight data traffic model generated using machine learning and trained using past quality of service data representative of past qualities of service of past data traffic flows via the network, from prior to the data traffic flows, and past scheduling weight settings applied to the past data traffic flows, determining a scheduling weight setting to be applied to a data traffic flow of the data traffic flows, and applying the scheduling weight setting to the data traffic flow.